IM Cannabis Corp (TSE:IMCC) has released an update.
IM Cannabis Corp. has terminated its preliminary agreement with Kadimastem Ltd. to concentrate on the burgeoning German market following the country’s cannabis legalization. The company is repaying a $300,000 loan to Kadimastem, plus interest, and is optimistic about Germany’s potential to become a major legal cannabis market. IMC is strategically refocusing on Israel and Germany, aiming to maximize shareholder value through its established medical cannabis operations and distribution networks.
For further insights into TSE:IMCC stock, check out TipRanks’ Stock Analysis page.
